{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T17:53:04Z","timestamp":1723053184735},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,9,9]],"date-time":"2010-09-09T00:00:00Z","timestamp":1283990400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s10157-010-0343-7","type":"journal-article","created":{"date-parts":[[2010,9,8]],"date-time":"2010-09-08T01:02:08Z","timestamp":1283907728000},"page":"58-63","source":"Crossref","is-referenced-by-count":12,"title":["Elevated serum levels of interleukin-18 in patients with overt diabetic nephropathy: effects of miglitol"],"prefix":"10.1007","volume":"15","author":[{"given":"Takashi","family":"Uzu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Koya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Maegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiyo","family":"Yokomaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ichi","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Abiko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Haneda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,9]]},"reference":[{"key":"343_CR1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2337\/diabetes.48.5.937","volume":"48","author":"M Laakso","year":"1999","unstructured":"Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes. 1999;48:937\u201342.","journal-title":"Diabetes"},{"key":"343_CR2","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1001\/jama.287.19.2570","volume":"2002","author":"JA Beckman","year":"2002","unstructured":"Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology and management. JAMA. 2002;2002:2570\u201381.","journal-title":"JAMA"},{"key":"343_CR3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1523-1755.2003.00712.x","volume":"63","author":"AI Adler","year":"2003","unstructured":"Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003;63:225\u201332.","journal-title":"Kidney Int"},{"key":"343_CR4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115\u201326.","journal-title":"N Engl J Med"},{"key":"343_CR5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1172\/JCI1379","volume":"101","author":"AJ Puren","year":"1998","unstructured":"Puren AJ, Fantuzzi G, Gu Y, Su MS, Dinarello CA. Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. J Clin Invest. 1998;101:711\u201321.","journal-title":"J Clin Invest"},{"key":"343_CR6","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1161\/ATVBAHA.107.149484","volume":"27","author":"A Zirlik","year":"2007","unstructured":"Zirlik A, Abdullah SM, Gerdes N, MacFarlane L, Sch\u00f6nbeck U, Khera A, et al. Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis: results from the Dallas Heart Study. Arterioscler Thromb Vasc Biol. 2007;27:2043\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"343_CR7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.atherosclerosis.2008.04.015","volume":"202","author":"BM Everett","year":"2009","unstructured":"Everett BM, Bansal S, Rifai N, Buring JEPMR. Interleukin-18 and the risk of future cardiovascular disease among initially healthy women. Atherosclerosis. 2009;202:282\u20138.","journal-title":"Atherosclerosis"},{"key":"343_CR8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jdiacomp.2005.02.008","volume":"19","author":"P Skopi\u0144ski","year":"2005","unstructured":"Skopi\u0144ski P, Rogala E, Duda-Kr\u00f3l B, Lipi\u0144ska A, Sommer E, Chorostowska-Wynimko J. Increased interleukin-18 content and angiogenic activity of sera from diabetic (Type 2) patients with background retinopathy. J Diabetes Complicat. 2005;19:335\u20138.","journal-title":"J Diabetes Complicat"},{"key":"343_CR9","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.2337\/diacare.28.12.2890","volume":"28","author":"A Nakamura","year":"2005","unstructured":"Nakamura A, Shikata K, Hiramatsu M, Nakatou T, Kitamura T, Wada J, et al. Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes. Diabetes Care. 2005;28:2890\u20135.","journal-title":"Diabetes Care"},{"key":"343_CR10","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00125-006-0586-8","volume":"50","author":"S Araki","year":"2007","unstructured":"Araki S, Haneda M, Koya D, Sugimoto T, Isshiki K, Chin-Kanasaki M, et al. Predictive impact of elevated serum level of IL-18 for early renal dysfunction in type 2 diabetes: an observational follow-up study. Diabetologia. 2007;50:867\u201373.","journal-title":"Diabetologia"},{"key":"343_CR11","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.2337\/dc06-9912","volume":"29","author":"DM Nathan","year":"2006","unstructured":"Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, et al. Management of hyperglycemia in Type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2006;29:1963\u201372.","journal-title":"Diabetes Care"},{"key":"343_CR12","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1464-5491.2008.02565.x","volume":"25","author":"A Ceriello","year":"2008","unstructured":"Ceriello A, Colagiuri S. International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations. Diabet Med. 2008;25:1151\u20136.","journal-title":"Diabet Med"},{"key":"343_CR13","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.clim.2005.07.008","volume":"117","author":"CP Fischer","year":"2005","unstructured":"Fischer CP, Perstrup LB, Berntsen A, Eskildsen P, Pedersen BK. Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans. Clin Immunol. 2005;117:152\u201360.","journal-title":"Clin Immunol"},{"key":"343_CR14","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1210\/jc.2007-0955","volume":"92","author":"C Herder","year":"2007","unstructured":"Herder C, Schneitler S, Rathmann W, Haastert B, Schneitler H, Winkler H, et al. Low-grade inflammation, obesity, and insulin resistance in adolescents. J Clin Endocrinol Metab. 2007;92:4569\u201374.","journal-title":"J Clin Endocrinol Metab"},{"key":"343_CR15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cyto.2008.02.006","volume":"42","author":"AE Altinova","year":"2008","unstructured":"Altinova AE, Yetkin I, Akbay E, Bukan N, Arslan M. Serum IL-18 levels in patients with type 1 diabetes: relations to metabolic control and microvascular complications. Cytokine. 2008;42:217\u201321.","journal-title":"Cytokine"},{"key":"343_CR16","first-page":"734","volume":"47","author":"HJ Ahr","year":"1997","unstructured":"Ahr HJ, Boberg M, Brendel E, Krause HP, Steinke W. Pharmacokinetics of miglitol Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man. Arzneimittelforschung. 1997;47:734\u201345.","journal-title":"Arzneimittelforschung"},{"key":"343_CR17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1021\/ac00268a010","volume":"56","author":"GO Guerrant","year":"1984","unstructured":"Guerrant GO, Moss CW. Determination of monosaccharides as aldononitrile, o-methyloxime, alditol, and cyclitol acetate derivatives by gas chromatography. Anal Chem. 1984;56:633\u20138.","journal-title":"Anal Chem"},{"key":"343_CR18","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982\u201392.","journal-title":"Am J Kidney Dis"},{"key":"343_CR19","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1161\/01.HYP.37.4.1053","volume":"37","author":"JR Sowers","year":"2001","unstructured":"Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension. 2001;37:1053\u20139.","journal-title":"Hypertension"},{"key":"343_CR20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJMe020172","volume":"348","author":"CG Solomon","year":"2003","unstructured":"Solomon CG. Reducing cardiovascular risk in type 2 diabetes. N Engl J Med. 2003;348:457\u20139.","journal-title":"N Engl J Med"},{"key":"343_CR21","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/hc3901.096721","volume":"104","author":"Z Mallat","year":"2001","unstructured":"Mallat Z, Corbaz A, Scoazec A, Besnard S, Les\u00e8che G, Chvatchko Y, et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation. 2001;104:1598\u2013603.","journal-title":"Circulation"},{"key":"343_CR22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cyto.2009.06.002","volume":"47","author":"P Welsh","year":"2009","unstructured":"Welsh P, Woodward M, Rumley A, Lowe G. Associations of circulating TNFalpha and IL-18 with myocardial infarction and cardiovascular risk markers: the Glasgow Myocardial Infarction Study. Cytokine. 2009;47:143\u20137.","journal-title":"Cytokine"},{"key":"343_CR23","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI200525102","volume":"115","author":"KE Wellen","year":"2005","unstructured":"Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115:1111\u20139.","journal-title":"J Clin Invest"},{"key":"343_CR24","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1089\/ars.2009.2705","volume":"11","author":"JG Dickhout","year":"2009","unstructured":"Dickhout JG, Krepinsky JC. Endoplasmic reticulum stress and renal disease. Antioxid Redox Signal. 2009;11:2341\u201352.","journal-title":"Antioxid Redox Signal"},{"key":"343_CR25","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813\u201320.","journal-title":"Nature"},{"key":"343_CR26","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1073\/pnas.97.2.734","volume":"97","author":"F Vidal-Vanaclocha","year":"2000","unstructured":"Vidal-Vanaclocha F, Fantuzzi G, Mendoza L, Fuentes AM, Anasagasti MJ, Mart\u00edn J, et al. L-18 regulates IL-1\u03b2-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. PNAS. 2000;97:734\u20139.","journal-title":"PNAS"},{"key":"343_CR27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-2362.2009.02228.x","volume":"40","author":"K Berneis","year":"2010","unstructured":"Berneis K, Rizzo M, Evans J, Rini GB, Spinas GA, Goedecke JH. Interleukin-18 levels are associated with low-density lipoproteins size. Eur J Clin Invest. 2010;40:54\u20135.","journal-title":"Eur J Clin Invest"},{"key":"343_CR28","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/ndt\/gfn486","volume":"24","author":"T Porazko","year":"2009","unstructured":"Porazko T, K\u00fazniar J, Kusztal M, K\u00fazniar TJ, Weyde W, Kuriata-Kordek M, et al. IL-18 is involved in vascular injury in end-stage renal disease patients. Nephrol Dial Transplant. 2009;24:589\u201396.","journal-title":"Nephrol Dial Transplant"},{"key":"343_CR29","first-page":"703","volume":"12","author":"UK Prospective Diabetes Study Group","year":"1999","unstructured":"UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1999;12:703\u201313.","journal-title":"BMJ"},{"issue":"Suppl 1","key":"343_CR30","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc09-S013","volume":"2009","author":"American Diabetes Association","year":"2009","unstructured":"American Diabetes Association. Standards of medical care in diabetes\u2013\u20132009. Diabetes Care. 2009;2009(Suppl 1):S13\u201361.","journal-title":"Diabetes Care"},{"issue":"Suppl4","key":"343_CR31","first-page":"73","volume":"26","author":"G Charpentier","year":"2000","unstructured":"Charpentier G, Riveline JP, Varroud-Vial M. Management of drugs affecting blood glucose in diabetic patients with renal failure. Diabetes Metab. 2000;26(Suppl4):73\u201385.","journal-title":"Diabetes Metab"},{"key":"343_CR32","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/ajcn\/79.6.969","volume":"79","author":"DJ Baer","year":"2004","unstructured":"Baer DJ, Judd JT, Clevidence BA, Tracy RP. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr. 2004;79:969\u201373.","journal-title":"Am J Clin Nutr"},{"key":"343_CR33","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.2337\/dc09-0979","volume":"32","author":"H Ghanim","year":"2009","unstructured":"Ghanim H, Abuaysheh S, Sia CL, Korzeniewski K, Chaudhuri A, Fernandez-Real JM. Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care. 2009;32:2281\u20137.","journal-title":"Diabetes Care"},{"key":"343_CR34","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.metabol.2008.04.027","volume":"57","author":"M Arakawa","year":"2008","unstructured":"Arakawa M, Ebato C, Mita T, Fujitani Y, Shimizu T, Watada H, et al. Miglitol suppresses the postprandial increase in interleukin 6 and enhances active glucagon-like peptide 1 secretion in viscerally obese subjects. Metabolism. 2008;57:1299\u2013306.","journal-title":"Metabolism"},{"key":"343_CR35","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s00125-005-1849-5","volume":"48","author":"R Assaloni","year":"2005","unstructured":"Assaloni R, Da Ros R, Quagliaro L, Piconi L, Maier A, Zuodar G, et al. Effects of S21403 (mitiglinide) on postprandial generation of oxidative stress and inflammation in type 2 diabetic patients. Diabetologia. 2005;48:1919\u201324.","journal-title":"Diabetologia"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-010-0343-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-010-0343-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-010-0343-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T03:24:05Z","timestamp":1559618645000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-010-0343-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,9]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["343"],"URL":"https:\/\/doi.org\/10.1007\/s10157-010-0343-7","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,9]]}}}